Skip to content

Clinical trials

Completed Phase 3 Dyspareunia trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Dyspareunia Phase: Phase 3 Status: Completed Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20091
20111
20131
20142
20161
20181
20191
20202
20211
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed13

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Kissei Pharmaceutical Co., Ltd.2
AbbVie1
Duramed Research1
Fred Hutchinson Cancer Center1
Instituto Palacios1
Myovant Sciences GmbH1
OHSU Knight Cancer Institute1
Reckitt Benckiser Healthcare (UK) Limited1
Seoul National University Hospital1
Teva Pharmaceuticals USA1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Dyspareunia13
Dysmenorrhea4
Endometriosis4
Breast Neoplasms2
Constipation2
Pain1
Pelvic Pain1
Sexual Dysfunction, Physiological1
Vulvodynia1

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.